Google

> Quick Quote


view

Challenges in Cardiovascular Intervention:
Management of Combined Coronary and Carotid Disease

October 14, 2007
 Charles B. Wang Center, Stony Brook University Stony Brook, New York

Course Director:
John J. Ricotta, MD

Dear Colleague,

Managing clinically significant coexistent lesions in the coronary and carotid circulations continues to be a vexing problem for cardiologists, neurologists, and cardiovascular surgeons. This situation is seen in 3-8% of patients who present for coronary revascularization and as many as 10% of patients who present for carotid revascularization. While advances in the endoluminal therapy of atherosclerosis have opened new treatment options for these patients, optimal management algorithms have yet to be developed.

We would like to invite you to participate in a symposium on the current treatment of combined coronary and carotid disease. The purpose will be to review the historical data on managing patients with combined coronary and carotid disease, discuss the current state-of-the-art, and hopefully plan a prospective trial to evaluate the role of carotid stenting for these patients. The conference will be held at the Wang Center at Stony Brook University on October 14, 2007. This think tank will be held on Sunday following the one-day symposium on “Meeting of the Minds: Emergent Therapies in Cardiovascular Disease, Outcomes and Evidence-Based Medicine” which is being directed by our Division of Cardiothoracic Surgery along with Cardiology.

As a clinician who treats patients with advanced atherosclerotic disease we hope you will be interested in this topic and look forward to seeing you here on Long Island in October of 2007. For additional information, please call 631-444-8140.

Sincerely and with best regards,

John J. Ricotta, MD
Professor and Chair
Department of Surgery
SUNY Stony Brook
Stony Brook, NY

COURSE OBJECTIVES

  • Review the historical data on managing patients with combined coronary and carotid disease and discuss the current state-of-the-art treatment
  • Plan a prospective trial to evaluate the role of carotid stenting for these patients
  • Discuss the potential role of carotid endarterectomy and carotid stenting in association with coronary bypass

TARGET AUDIENCE
 This symposium is designed for cardiologists, neurologists, cardiothoracic surgeons, and vascular/neurovascular surgeons.

This program is made possible by:
 NINDS Grant # RO1 39336-02 & NIH Grant # MO1 RR10710

LOCATION
 The symposium will take place in the Charles B. Wang Center at Stony Brook University, Stony Brook, New York.

HOTEL ACCOMMODATIONS
 Please contact Rebecca Law at rlaw@promedicacme.com for a list of recommended hotels.

REGISTRATION
 This satellite symposium will be held Sunday following the “Meeting of the Minds: Emergent Therapies in Cardiovascular Disease, Outcomes and Evidence-Based Medicine” course on October 13th.

To register please visit www.promedicacme.com. Registration for this “think tank” is complimentary. No registrations will be taken over the phone and must be submitted in writing.

ACTIVITY EVALUATION
 Evaluation by questionnaire will address content, presentation and future educational needs.

INVITED FACULTY
 R. CLEMENT DARLING III, MD
Professor of Surgery
Chief, Division of Vascular Surgery
Albany Medical College /
Albany Medical Center Hospital
The Vascular Group, PLLC
Albany, NY

PETER L. FARIES, MD
 Associate Professor of Surgery
Weill Medical College of Cornell
University
New York, NY

JOHN MARLER, MD
 Associate Director for Clinical
Trials National Institutes of
Neurological Disorders and Stroke
National Institutes of Health
Rockville, MD

APOSTOLOS TASSIOPOULOS, MD
 Assistant Professor of Vascular Surgery
SUNY at Stony Brook
Stony Brook, NY

DISCLOSURE STATEMENT
 It is the policy of Promedica International, a California Corporation to ensure fair balance, independence, objectivity and scientific rigor in all its sponsored programs. All faculty members participating in sponsored programs are expected to disclose to the audience any real or apparent conflict-of-interest related to the content of their presentation, and any discussions of unlabeled or investigational use of any commercial product or device not yet approved in the United States.

CME ACCREDITATION AND DESIGNATION
 Promedica International CME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Promedica International CME designates this educational activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.